GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mezzion Pharma Co (XKRX:140410) » Definitions » Cyclically Adjusted Revenue per Share

Mezzion Pharma Co (XKRX:140410) Cyclically Adjusted Revenue per Share : ₩0.00 (As of Sep. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Mezzion Pharma Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Mezzion Pharma Co's adjusted revenue per share for the three months ended in Sep. 2024 was . Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₩0.00 for the trailing ten years ended in Sep. 2024.

During the past 12 months, Mezzion Pharma Co's average Cyclically Adjusted Revenue Growth Rate was -100.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-12-15), Mezzion Pharma Co's current stock price is ₩32850.00. Mezzion Pharma Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2024 was ₩0.00. Mezzion Pharma Co's Cyclically Adjusted PS Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Mezzion Pharma Co was 116.87. The lowest was 18.07. And the median was 45.98.


Mezzion Pharma Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Mezzion Pharma Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mezzion Pharma Co Cyclically Adjusted Revenue per Share Chart

Mezzion Pharma Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 647.74 713.97 806.81

Mezzion Pharma Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 790.93 806.81 812.35 - -

Competitive Comparison of Mezzion Pharma Co's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - General subindustry, Mezzion Pharma Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mezzion Pharma Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mezzion Pharma Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Mezzion Pharma Co's Cyclically Adjusted PS Ratio falls into.



Mezzion Pharma Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Mezzion Pharma Co's adjusted Revenue per Share data for the three months ended in Sep. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=76.044/*
=

Current CPI (Sep. 2024) = .

Mezzion Pharma Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201412 144.041 99.098 0.000
201503 469.173 99.720 0.000
201506 53.921 100.050 0.000
201509 64.570 100.110 0.000
201512 67.629 100.220 0.000
201603 49.188 100.560 0.000
201606 108.173 100.790 0.000
201609 59.018 101.460 0.000
201612 179.385 101.560 0.000
201703 60.041 102.850 0.000
201706 53.230 102.610 0.000
201709 49.314 103.490 0.000
201712 86.218 102.990 0.000
201803 220.837 104.100 0.000
201806 182.910 104.130 0.000
201809 494.215 105.650 0.000
201812 212.940 104.350 0.000
201903 188.913 104.490 0.000
201906 165.742 104.880 0.000
201909 164.138 105.200 0.000
201912 197.940 105.120 0.000
202003 195.308 105.540 0.000
202006 233.531 104.870 0.000
202009 258.741 106.200 0.000
202012 415.694 105.765 0.000
202103 221.297 107.357 0.000
202106 80.393 107.579 0.000
202109 88.184 108.759 0.000
202112 271.893 109.676 0.000
202203 83.167 111.806 0.000
202206 309.086 114.083 0.000
202209 256.359 114.831 0.000
202212 289.960 115.200 0.000
202303 289.955 116.550 0.000
202306 298.561 117.140 0.000
202309 284.483 119.111 0.000
202312 249.420 118.848 0.000
202403 72.877 118.848 0.000
202406 77.116 0.000
202409 76.044 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Mezzion Pharma Co  (XKRX:140410) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Mezzion Pharma Co was 116.87. The lowest was 18.07. And the median was 45.98.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Mezzion Pharma Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Mezzion Pharma Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Mezzion Pharma Co Business Description

Industry
Traded in Other Exchanges
N/A
Address
C&H, Samseong-dong, 154-8, Gangnam-gu, Dongdaemun-gu, Seoul, KOR, 135-879
Mezzion Pharma Co is a South Korea based drug manufacturer company. It develops and manufactures pharmaceutical products for erectile dysfunction and benign prostatic hyperplasia.

Mezzion Pharma Co Headlines

No Headlines